N. Nagarsheth
Immunology · 2015–2017
A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 68 citations into it
- Oncology — 65 citations into it
Whom N. Nagarsheth trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts N. Nagarsheth overall
Papers from N. Nagarsheth's perspective
Ordered by how strongly the researchers N. Nagarsheth trusts endorse each paper. Same corpus, a different order for every researcher.
- HTSeq—a Python framework to work with high-throughput sequencing data (bioRxiv)
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota (Science)
- The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide (Science)
- Intestinal inflammation targets cancer-inducing activity of the microbiota (Science)
- Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. (Genome Research)
- Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. (Genome Research)
- TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions (Genome Biology)
- Metagenomic biomarker discovery and explanation (Genome Biology)
- Cancer and the microbiota (Science)
- The resurgence of platinum-based cancer chemotherapy (Nature Reviews. Cancer)
Their papers
- Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy (2017) — 1,913 citations
- Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy (2017) — 1,861 citations
- Epigenetic silencing of Th1 type chemokines shapes tumor immunity and immunotherapy (2015) — 1,069 citations